|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 | |
| C07K 1/22 |
| (11) | Patento numeris | 3472314 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17814267.5 |
| Europos patento paraiškos padavimo data | 2017-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/038169 |
| Data | 2017-06-19 |
| (87) | Numeris | WO 2017/219034 |
| Data | 2017-12-21 |
| (30) | Numeris | Data | Šalis |
| 201662351841 P | 2016-06-17 | US |
| (72) |
KARBARZ, Mark, US
CONLEY, Pamela B., US
LU, Genmin, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | PREPARATION OF FACTOR XA DERIVATIVES |
| PREPARATION OF FACTOR XA DERIVATIVES |